Stockbroker tips from ShareCast
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
Berenberg raises target price on SSE
Thu 17 September 2026 07:28
(Sharecast News) - Analysts at Berenberg lifted their target price for energy provider SSE from 2,800p to 2,980p on Thursday, reiterating the stock as their top sector pick and arguing that the market was still failing to reflect the firm's "unprecedented
Deutsche Bank hikes Kier price target
Wed 16 September 2026 14:02
(Sharecast News) - Deutsche Bank hiked its price target on Kier on Wednesday to 330p from 295p after the company said a day earlier that 2027 earnings were set to be at the top end of its expectations, and that it will not be making any more investments i
Broker tips: GSK, Astrazeneca, Vodafone
Tue 15 September 2026 12:54
(Sharecast News) - Analysts at Berenberg upgraded drugmaker GSK from 'hold' to 'buy' on Tuesday and lifted their target price on the stock from £20 to £22, saying recent business‑development activity and pipeline momentum had strengthened the firm
Deutsche Bank upgrades Astrazeneca to 'hold'
Tue 15 September 2026 12:42
(Sharecast News) - Deutsche Bank upgraded Astrazeneca from 'sell' to 'hold' on Tuesday and nudged its price target up from 11,500p to 11,700p, saying the risk‑reward scenario had shifted following last week's negative SERENA-4 readout and a period of un
Berenberg upgrades GSK to 'buy', raises target price
Tue 15 September 2026 07:24
(Sharecast News) - Analysts at Berenberg upgraded drugmaker GSK from 'hold' to 'buy' on Tuesday and lifted their target price on the stock from £20 to £22, saying recent business‑development activity and pipeline momentum had strengthened the firm
Broker tips: Antofagasta, Cerillion
Mon 14 September 2026 13:59
(Sharecast News) - Analysts at Berenberg upgraded Antofagasta from 'hold' to 'buy' on Monday, saying last week's sharp pullback in copper prices had created an attractive entry point, while keeping its 4,400p price target unchanged for around 16% upside.